Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
At Boston University School of Medicine, a research team led by Lee Goldstein, MD, PhD, identified the mechanism of chronic traumatic encephalopathy (CTE). This neurodegenerative disease is associated…
An innovative device developed by Klick Labs can recreate parkinsonian tremor in healthy individuals. Designed to increase empathy among caregivers, SymPulse Tele-Empathy Device records a patient’s hand tremors…
Physician experts observe that patients with Parkinson’s disease don’t always eat enough to meet their energy needs, which are typically higher than those of non-Parkinson’s patients.
Researchers at the National University of Ireland Galway use biomaterials to protect neurons transplanted to the brain for the treatment of Parkinson’s disease.
A team of engineers are hoping the 12-sided cage they developed will one day help fight cancer. Made from self-assembling silica, the nanocage is only 11 nanometers across—for…
